NDC 43598-642 – Dabigatran etexilate
Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Oral
Product NDC43598-642
Product details
- Brand name
- Dabigatran etexilate
- Generic name
- Dabigatran etexilate
- Labeler
- Dr.Reddys Laboratories Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA208048
- Marketed since
- February 28, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Direct Thrombin Inhibitor
Active ingredients
- Dabigatran Etexilate Mesylate 75 mg/1
Uses, dosage, side effects and warnings for Dabigatran Etexilate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 43598-642-60 | 60 CAPSULE in 1 BOTTLE (43598-642-60) | Feb 28, 2025 |
Other Dabigatran Etexilate products
- 62332-636 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-635 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-634 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-634 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-635 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-636 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60505-4347 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Apotex Corp.
- 60505-4348 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Apotex Corp.
- 60505-4349 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Apotex Corp.
- 59651-973 Dabigatran Etexilate Mesylate 75 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-974 Dabigatran Etexilate Mesylate 110 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-975 Dabigatran Etexilate Mesylate 150 mg/1 · Capsule · Aurobindo Pharma Limited